Urogen Pharma Ltd
General ticker "URGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $512.1M
Urogen Pharma Ltd does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 2.5%: low 10.43$, high 10.97$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [10.00$, 22.70$]
- 2024-12-30 to 2025-12-30 estimated range: [8.28$, 19.52$]
Financial Metrics affecting the URGN estimates:
- Negative: Non-GAAP EPS, $ of -3.73 <= 0.10
- Negative: Operating profit margin, % of -44.21 <= 1.03
- Negative: Operating cash flow per share per price, % of -15.73 <= 2.35
- Positive: Inventory ratio change, % of 0.97 <= 1.08
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term URGN quotes
Long-term URGN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $48.04MM | $64.36MM | $82.71MM |
| Operating Expenses | $140.33MM | $143.40MM | $148.25MM |
| Operating Income | $-92.29MM | $-79.04MM | $-65.54MM |
| Non-Operating Income | $-17.08MM | $-28.99MM | $-32.79MM |
| Interest Expense | $17.44MM | $8.44MM | $14.71MM |
| R&D Expense | $47.64MM | $52.91MM | $45.61MM |
| Income(Loss) | $-109.37MM | $-108.03MM | $-98.32MM |
| Taxes | $1.45MM | $1.14MM | $3.92MM |
| Profit(Loss) | $-110.82MM | $-109.16MM | $-102.24MM |
| Stockholders Equity | $8.41MM | $0.06MM | $-65.21MM |
| Inventory | $4.83MM | $4.33MM | $5.67MM |
| Assets | $119.75MM | $135.62MM | $178.31MM |
| Operating Cash Flow | $-84.89MM | $-87.56MM | $-76.38MM |
| Capital expenditure | $0.75MM | $0.25MM | $0.19MM |
| Investing Cash Flow | $4.07MM | $1.06MM | $-0.95MM |
| Financing Cash Flow | $72.32MM | $97.13MM | $116.93MM |
| Earnings Per Share* | $-4.96 | $-4.79 | $-3.55 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.